![Kristin Stafford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristin Stafford
Directeur Financier/CFO chez
ZYMEWORKS INC.
Fortune : 390 795 $ au 31/05/2026
Profil
Kristin Stafford is currently an Independent Director at NovoCure Ltd. since 2023.
Ms. Stafford is Chief Accounting Officer & Senior Vice President at Royalty Pharma Plc since 2018, with the role starting in 2016.
Ms. Stafford is Chief Financial Officer & Executive Vice President at Zymeworks, Inc. starting in 2026.
Formerly, Ms. Stafford was Director-Capital Markets at Ernst & Young LLP (United Kingdom) from 2014 to 2016.
Ms. Stafford was an Auditor at Deloitte & Touche LLP from 2004 to 2008.
Ms. Stafford was Chief Financial Officer at BioPharma Credit PLC from 2016 to 2018.
Ms. Stafford completed undergraduate education at Sonoma State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD. 0,02% | 03/06/2026 | 22 934 ( 0,02% ) | 390 795 $ | 31/05/2026 |
Postes actifs de Kristin Stafford
| Sociétés | Poste | Début |
|---|---|---|
| ROYALTY PHARMA PLC | Comptroller/Controller/Auditor | 01/12/2018 |
| NOVOCURE LIMITED | Directeur/Membre du Conseil | 28/03/2023 |
| ZYMEWORKS INC. | Directeur Financier/CFO | 01/04/2026 |
Anciens postes connus de Kristin Stafford
| Sociétés | Poste | Fin |
|---|---|---|
| BIOPHARMA CREDIT PLC | Directeur Financier/CFO | 01/01/2018 |
Ernst & Young LLP (United Kingdom)
 Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Corporate Officer/Principal | 01/12/2016 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01/05/2008 |
Formation de Kristin Stafford
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Sonoma State University
 Sonoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (United Kingdom)
Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Commercial Services |
NovoCure Ltd.
 NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
BioPharma Credit PLC
 BioPharma Credit PLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
